The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Trademark litigation for Chippendales
Represented Chippendales in trademark infringement suit against manufacturer and distributor of Chickendales slot machine. Resulted in a successful more
Employment litigation for a national fast food restaurant chain
Represented a national fast food restaurant chain in several workplace violence cases where patrons, along with the restaurant employees who came to more
Patent prosecution and counseling for patent legal services for public health agency
Represented public health agency in patent prosecution and counseling matters. Prepared and prosecuted patent applications in a variety of more
Hospital/Physician Joint Venture
Represented Ty Cobb Healthcare in formation of hospital-physician joint venture. Joint Venture formed to own and operate a new consolidated hospital more